Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia. 24234650 2014
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population. 17964958 2007
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR High frequency of the ApoB-100 R3500Q mutation in Bulgarian hypercholesterolaemic subjects. 11494965 2001
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. 8371062 1993
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500-->tryptophan mutation associated with a unique haplotype. 9191540 1997
Familial hypercholesterolemia - homozygous
0.200 Biomarker disease BEFREE Here, we have used hepatocyte-like cells generated from homozygous familial hypercholesterolemia (hoFH) iPSCs to identify drugs that can potentially be repurposed to lower serum LDL-C. We found that cardiac glycosides reduce the production of apolipoprotein B (apoB) from human hepatocytes in culture and the serum of avatar mice harboring humanized livers. 28388428 2017
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary. 11137107 2001
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Identification of the haplotype associated with the APOB-3500 mutation in a French hypercholesterolemic subject: further support for a unique European ancestral mutation. 8318993 1993
Familial hypercholesterolemia - homozygous
0.200 Biomarker disease BEFREE An oral fat load was given, and chylomicron plasma kinetics was determined by monitoring the clearance of triglyceride, retinyl palmitate and apolipoprotein B48, calculated as the area under the curve, for 7.5 h. In addition, the binding and uptake of chylomicron remnants by fibroblasts of FH and control subjects were assessed in vitro. 9650011 1998
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects. 25461735 2015
Familial hypercholesterolemia - homozygous
0.200 Biomarker disease BEFREE Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia. 9626156 1998
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia. 11238294 2001
Familial hypercholesterolemia - homozygous
0.200 Biomarker disease BEFREE Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. 2715722 1989
Familial hypercholesterolemia - homozygous
0.200 Biomarker disease BEFREE Inhibition of apolipoprotein B synthesis by mipomersen represents a novel, effective therapy to reduce LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia who are already receiving lipid-lowering drugs, including high-dose statins. 20227758 2010
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China. 22353362 2012
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. 2563166 1989
Familial hypercholesterolemia - homozygous
0.200 Biomarker disease BEFREE Mipomersen, an apolipoprotein B (ApoB) synthesis inhibitor, for lowering of LDL-C showed to be an effective therapy to reduce LDL-C concentrations in patients with HoFH who are already receiving lipid-lowering drugs, including high-dose statins. 22963620 2012
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are. 10529757 1999
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. 24784157 2014
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia. 10208479 1999
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100. 8723684 1996
Familial hypercholesterolemia - homozygous
0.200 GeneticVariation disease CLINVAR Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. 22408029 2012
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. 1793440 1991
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect. 18096825 2008
Familial hypercholesterolemia - homozygous
0.200 CausalMutation disease CLINVAR Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients. 11833852 2001